Left ventricular mitogen activated protein kinase signaling following polymicrobial sepsis during streptozotocin-induced hyperglycemia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1690, Issue 1, 2004, Pages 42-53

  Gupta, Akanksha ^a   Brahmbhatt, Sachin ^a   Sharma, Avadhesh C ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Endothelin 1; Left ventricular end diastolic pressure; Nitric oxide synthase; Signaling; SIRS

Indexed keywords

ENDOTHELIN 1; GLUCOSE; HEAT SHOCK PROTEIN 27; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HYPERGLYCEMIA; HYPOTHESIS; INOCULATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEPSIS; STATISTICAL SIGNIFICANCE; UPREGULATION; WEIGHT REDUCTION;

ANIMALS; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; HYPERGLYCEMIA; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4344668354     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.05.001     Document Type: Article

References (52)

1. Hostetter M.K. Handicaps to host defense: effects of hyperglycemia on C3 and Candida albicans. Diabetes. 39:1990;271-275
2. Lewis J., Fekety F.R. Gram-negative bacteremia. Johns Hopkins Med. J. 124:1969;106-111
3. Glauser M.P., Zannetti G., Baumgartner J.-D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-736
4. Penpargkul S., Fein F., Sonnenblick E.H., Scheuer J. Depressed cardiac sarcoplasmic reticular function from diabetic rats. J. Mol. Cell. Cardiol. 13:1981;303-309
5. Clark R.J., McDonough P.M., Swanson E., Trost S.U., Suzuki M., Fukuda M., Dillmann W.H. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J. Biol. Chem. 278:2003;44230-44237
6. Sharma A.C., Motew S.J., Farias S., Alden K.J., Bosmann H.B., Law W.R., Ferguson J.L. Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J. Mol. Cell. Cardiol. 29:1997;1469-1477
7. Ren J., Ren B.H., Sharma A.C. Sepsis-induced depressed contractile function of isolated ventricular myocytes is due to altered calcium transient properties. Shock. 18:2002;285-288
8. Song G.Y., Chung C.S., Jarrar D., Cioffi W.G., Ayala A. Mechanism of immune dysfunction in sepsis: inducible nitric oxide-meditated alterations in p38 MAPK activation. J. Trauma. 53:2002;276-282
9. Haneda M., Araki S., Togawa M., Sugimoto T., Isono M., Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes. 46:1997;847-853
10. Kumar S., Boehm J., Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev., Drug Discov. 2:2003;717-726
11. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869
12. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13:2001;85-94
13. Clerk A., Michael A., Sugden P.H. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J. Cell Biol. 142:1998;523-535
14. Liu W., Kato M., Itoigawa M., Murakami H., Yajima M., Wu J., Ishikawa N., Nakashima I. Distinct involvement of NF-κB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J. Cell. Biochem. 83:2001;271-280
15. Naito Z., Takashi E., Xu G., Ishiwata T., Teduka K., Yokoyama M., Yamada N., Sugisaki Y., Asano G. Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp. Mol. Pathol. 74:2003;23-32
16. Fogelson B.G., Nawas S.I., Vigneswaran W.T., Ferguson J.L., Law W.R., Sharma A.C. Diabetic patients produce an increase in coronary sinus endothelin-1 after coronary artery bypass grafting. Diabetes. 47:1998;1161-1163
17. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516
18. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27:1996;567-574
19. Stockklauser-Farber K., Ballhausen T., Laufer A., Rosen P. Influence of diabetes on cardiac nitric oxide synthase expression and activity. Biochim. Biophys. Acta. 1535:2000;10-20
20. Zhao G., Zhang X., Smith C.J., Xu X., Ochoa M., Greenhouse D., Vogel T., Curran C., Hintze T.H. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am. J. Physiol. 277:1999;H268-H278
21. Kobayashi T., Kamata K. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atherosclerosis. 155:2001;313-320
22. Omachi A., Sharma C., Alden K.J., Sam A.D., Ferguson J.L. Induction of peritoneal sepsis increases the susceptibility of isolated hearts to a calcium paradox-mediated injury. Shock. 17:2002;193-198
23. Gupta A., Sharma A.C. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia. Shock. 20:2003;375-381
24. Pollock J.S., Nakane M., Buttery L.D.K., Martinez A., Springdall J.M., Polak J.M., Forstermann U., Murad F. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am. J. Physiol. 265:1993;C1379-C1387
25. Le-Marchand-Brustel Y., Freychet P. Effect of fasting and streptozotocin diabetes insulin binding and action in the isolated mouse soleus muscle. J. Clin. Invest. 64:1979;1505-1515
26. Bedoya F.J., Solano F., Lucas M. N-Monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia. 52:1996;344-347
27. Bar-On H., Roheim P.S., Eder H.E. Hyperlipoproteinemia in streptozotocin-treated rats. Diabetes. 25:1976;509-515
28. Mulder P., Richard V., Bouchart F., Derumeaux G., Munter K., Thuillez C. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure. Cardiovasc. Res. 39:1998;600-608
29. Brahmbhatt S., Gupta A., Sharma A.C. Effect of endothelin-1 (ET-1) precursor (big ET-1) on sepsis-induced left ventricular and diastolic pressure (LVEDP) and tau along with inducible nitric oxide synthase expression. FASEB J. 18:2004;A591
30. Mihm M.J., Seifert J.L., Coyle C.M., Bauyer J.A. Diabetes related cardiomyopathy time dependent echocardiographic evaluation in an experimental rat model. Life Sci. 69:2001;527-542
31. Law W.R., Moriarty M.T., McLane M.P. Cardiovascular sequelae of endotoxin shock in diabetic dogs. Diabetolgia. 34:1991;687-694
32. Oguri S., Motegi K., Endo Y. Augmented lipopolysaccharide-induction of the histamine-forming enzyme in streptozotocin-induced diabetic mice. Biochim. Biophys. Acta. 1637:2003;83-90
33. Yalda B., Offenbacher S., Collins J.G. Diabetes as a modifier of periodontal disease expression. Periodontology 2000. 1994;37-49
34. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock - a review of laboratory models and a proposal. J. Surg. Res. 29:1980;189-201
35. Bone R.C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and what we do not know about cytokine regulation. Crit. Care Med. 24:1996;163-172
36. Makino A., Kamata K. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br. J. Pharmacol. 123:1998;1065-1072
37. Takahashi K., Suda K., Lam H.C., Ghatei M.A., Bloom S.R. Endothelin-like immunoreactivity in rat models of diabetes mellitus. J. Endocrinol. 130:1991;123-127
38. Shin S.J., Lee Y.J., Lin S.R., Tan M.S., Lai Y.H., Tsai J.H. Decrease of renal endothelin 1 content and gene expression in diabetic rats with 4-wk hyperglycemia. Nephron. 70:1995;486-493
39. Suzuki T., Kumazaki T., Mitsui Y. Endothelin-1 is produced and secreted by neonatal rat cardiac myocytes in vitro. Biochem. Biophys. Res. Commun. 191:1993;823-830
40. Vermes I., Spooren P.F., Kalsbeek-Batenburg E.M., Haanen C. In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia. 36:1993;472-473
41. Boulanger C., Luscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85:1990;587-590
42. Sharma A.C., Chen H., Gupta A. Upregulated myocardial and renal inducible nitric oxide synthase and preproET-1 during diabetes following sepsis. FASEB J. 17:2003;A642
43. Chauhan S.D., Seggara G., Vo P.A., Macallister R.J., Hobbs A.J., Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J. 17:2003;773-775
44. Gupta A., Sharma A.C. Despite minimal hemodynamic alterations endotoxemia modulates NOS and p38-MAPK phosphorylation via metalloendopeptidases. Mol. Cell. Biochem. 2003;. (in press)
45. Ding Y., Vaziri N.D., Coulson R., Kamanna V.S., Roh D.D. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am. J. Physiol., Endocrinol. Metab. 279:2000;E11-E17
46. Mancusi G., Hutter C., Baumgartner-Parzer S., Schmidt K., Schutz W., Sexl V. High-glucose incubation of human umbilical-vein endothelial cells does not alter expression and function either of G-protein alpha-subunits or of endothelial NO synthase. Biochem. J. 315:1996;281-287
47. Cosentino F., Hishikawa K., Katusic Z.S., Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation. 96:1997;25-28
48. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest. 91:1993;1367-1373
49. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z.Y., Yamauchi T., Kuboki K., Meier M., Rhodes C.J., King G.L. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J. Clin. Invest. 103:1999;185-195
50. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037
51. LaPointe M.C., Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/p44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension. 33:1999;276-282
52. Purves T., Middlemas A., Agthong S., Jude E.B., Boulton A.J., Fernyhough P., Tomlinson D.R. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J. 15:2001;2508-2514